Cargando…
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review
The aim is to evaluate the published evidence on whether methotrexate (MTX) use causes progressive fibrotic interstitial lung disease (fILD). This PRISMA-compliant systematic review has been registered electronically with PROSPERO 2018 ID CRD42018087838, Centre of review and dissemination at the Uni...
Autores principales: | Dawson, Julie K., Quah, Edmond, Earnshaw, Ben, Amoasii, Constanta, Mudawi, Tareg, Spencer, Lisa G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079289/ https://www.ncbi.nlm.nih.gov/pubmed/33515067 http://dx.doi.org/10.1007/s00296-020-04773-4 |
Ejemplares similares
-
16. Reactivation of hepatitis B virus in a patient with psoriatic arthritis treated with methotrexate
por: Mudawi, Tareg, et al.
Publicado: (2017) -
10. Reactivation of hepatitis B virus in a patient with psoriatic arthritis treated with methotrexate
por: Mudawi, Tareg, et al.
Publicado: (2017) -
Progressive fibrotic interstitial lung disease
por: Pereira, Carlos A C, et al.
Publicado: (2023) -
Clinical Overview of Progressive Fibrotic Interstitial Lung Disease
por: Case, Amy Hajari
Publicado: (2022) -
Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars
por: Vanderstichele, Sophie, et al.
Publicado: (2022)